Congratulations 2022 Interest Group Award recipients!
Edwin Bierman Lecture Award
Gary Lewis, MD, FRCPC completed his medical training in 1982 at the University of Witwatersrand in South Africa, followed by specialty training in Internal Medicine and then Endocrinology at the University of Chicago. He joined the staff of the Toronto General Hospital in 1990, has served as Head of the Division of Endocrinology at University Health Network and Mount Sinai Hospitals (2001-2012), Director of the University of Toronto Division of Endocrinology and Metabolism (2008-2017) and Director of the Banting and Best Diabetes Centre, U of T (since 2011). Dr. Lewis is the Principal Investigator of a Diabetes Research network (Diabetes Action Canada) of over 110 investigators and 80 patient partners funded through the CIHR Strategy for Patient-Oriented Research (SPOR) Chronic Disease Network Initiative. He is a Full Professor in the Departments of Medicine and Physiology, University of Toronto and he holds the Sun Life Financial Chair in Diabetes and the Drucker Family Chair in Diabetes Research.
Dr. Lewis is recognized internationally as a foremost expert in the field of lipoprotein metabolism in insulin resistance and diabetes. He has made several important observations elucidating the mechanisms of diabetic dyslipidemia, most notably the multiorgan regulation of hepatic and intestinal lipoprotein secretion. His recent work examining molecular mechanisms of intestinal lipoprotein secretion have revealed the importance of lipid storage in enterocytes well after meal ingestion, and its subsequent mobilization by nutrients and hormones. Dr. Lewis has also contributed significantly to our understanding of the mechanisms of HDL lowering in insulin resistant/hypertriglyceridemic states, demonstrating that HDL lipid compositional changes enhance its clearance from the circulation. His research is notable for taking an integrative, whole body approach in both humans and animal models.
Please join us in celebrating Dr. Gary Lewis for outstanding contributions to the understanding of diabetes-related macrovascular complications.
Norbert Freinkel Lecture Award
Anny H. Xiang, PhD has undergrade and graduate training in biomedical engineering and physiology, and PhD in biostatistics. She co-led the University of Southern California (USC) Gestational Diabetes Study Group for more than a decade before moving to Kaiser Permanente Southern California to direct the Biostatistics Research Division.
Throughout her career, Dr. Xiang applied her multidisciplinary background to the design, conduct and interpretation of clinical research that addresses both mechanistic and clinical questions. During her time at USC, she was instrumental in defining how type 2 diabetes develops in young Hispanic women who have had gestational diabetes. She made the seminal discovery that diabetes can be prevented after gestational diabetes by reducing, rather than increasing insulin secretory load on the pancreas. At Kaiser Permanente, she conducted a series large population-based studies to assess the long-range adverse effects on offspring from diabetes during pregnancy and racial/ethnic disparities. She showed that child’s risks to autism, ADHD, asthma, growth, and obesity are all increased across the spectrum of maternal diabetes diagnosed relatively early or required medication treatment, type 2 and type 1 diabetes. Dr. Xiang also co-leads mechanistic studies to identify and understand brain pathways involved in the transgenerational transmission of obesity and diabetes to offspring.
Dr. Xiang has published over 160 peer reviewed research papers; 98 describe research findings in the fields of diabetes and gestational diabetes. Her work has provided important information for researchers studying diabetes and pregnancy, as well as for clinicians caring women with diabetes during pregnancy and their children.
Please join us in celebrating Dr. Anny Xiang for outstanding contributions to the understanding and treatment of diabetes in pregnancy.
Roger Pecoraro Lecture Award
Eric Senneville, MD, PhD, trained in medicine in Lille University, France before specializing from 1983 to 1991 in Cardiology, Nephrology, Internal Medicine and Infectious Diseases. He participated in the creation of multidisciplinary team for diabetic foot infections in 1996 with a special interest in the management of diabetic patients with osteomyelitis of the foot. Dr. Senneville has been consultant at the Department of Orthopedic surgery of the Lille University hospital since 1995. He is head of a 42-bed unit in the University Department of Infectious Diseases at the Gustave Dron hospital of Tourcoing, France and is since 2008 the coordinator of one of the 9 French national referent center for the management of patients with complex osteo-articular infections.
Dr .Senneville is chair for the expert panel of both the infectious Diseases Society of America (IDSA) and the International Working Group on the Diabetic Foot Infection (IWGDF) for the guidelines on the management of diabetic foot infections. He has authored more than 250 indexed review articles and original articles and over 30 textbook chapters
Please join us in recognizing Dr. Eric Senneville, for his contributions and commitment to improving the understanding of the detection, treatment, and prevention of diabetic foot complications.
Richard R. Rubin Lecture Award
Alan M. Delamater, PhD, ABPP received his BA in psychology from Carnegie Mellon University (1975) and PhD in clinical psychology from the University of Georgia (1981). He is currently Professor of Pediatrics and Psychology and Director of Clinical Psychology in the Department of Pediatrics, and Director of Research in the Mailman Center for Child Development at the University of Miami, where he has been since 1991. He was previously on the faculty at Washington University (1981-1987) and Wayne State University (1987-1991). Dr. Delamater has received many research grants from the NIH and has published widely in the field of pediatric behavioral medicine, focusing on diabetes and obesity. He is currently funded by NIH and PCORI on grants addressing health disparities in adolescents with type 1 diabetes and obesity prevention in ethnic minority children. He has served in leadership roles with the American Diabetes Association (ADA), American Psychological Association (APA), International Society of Pediatric and Adolescent Diabetes (ISPAD), and the Society of Behavioral Medicine (SBM). With the ADA, he was a member of the Scientific Sessions Planning Committee (1995-1997), Research Policy Committee (1998-2000), Associate Editor of Clinical Diabetes (2002-2006), and participated on two consensus reports published in Diabetes Care (2013, 2016). He was president of the APA’s Society of Pediatric Psychology (2007). With ISPAD, he was on the Advisory Council (2006-2008) and Conference President for the 2011 Annual Scientific Meeting. With SBM, he was Chair of the Council on Publications and Communications (2013-2016) and Senior Associate Editor for Translational Behavioral Medicine (2020-2022). Dr. Delamater is a Fellow of the APA and SBM. He has received multiple awards from SBM, including the LifeScan Diabetes Research Award (1997, 1999), the Tracy Orleans Distinguished Service Award (2016), the Lifetime Achievement Award from the Child and Family SIG (2017), and the Distinguished Mentor Award (2019). Dr. Delamater reviews regularly for professional journals and granting agencies, is active as a teacher and clinician, and is board-certified in clinical health psychology.
Please join us in celebrating Dr. Alan Delamater, for his contributions in behavioral medicine and diabetes.